Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Choosing VM Medical Park Samsun Hospital for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 2017, the JCI accredited hospital in Samsun, Turkey has 300 beds and provides specialized congenital heart disease services.
Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.
At VM Medical Park Ankara, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2014, this JCI accredited hospital in Ankara, Turkey has 327 beds and offers advanced interventional and congenital cardiology services.
Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.
Avcilar Anadolu Hospital offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 1998, the JCI accredited hospital is located in Istanbul, Turkey and has 120 beds, providing comprehensive cardiac care for local and international patients.
Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.
Carthage International Medical Center is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2014, the JCI- accredited hospital is situated in Monastir, Tunisia and has 120 beds.
Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.
NMC Chronic Care Specialized Hospital provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 2013, the CBAHI accredited hospital is located in Jeddah, Saudi Arabia and operates 120 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.
Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.
Werndale Hospital is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 1991, the - accredited hospital is situated in Carmarthen, United Kingdom and has 19 beds.
Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.
Burjeel Specialty Hospital, Sharjah offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 2019, the JCI accredited hospital is located in Sharjah, United Arab Emirates and has 75 beds, providing comprehensive cardiac care for local and international patients.
Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.
Choosing Ekol for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 2000, the ISO accredited hospital in Izmir, Turkey it has adequate bed capacity and provides specialized congenital heart disease services.
Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.
Arab Medical Center provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 1997, the JCI accredited hospital is located in Amman, Jordan and operates 243 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.
Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.
Choosing Ara Damansara Medical Centre for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 2012, the JCI, MSQH accredited hospital in Kuala Lumpur, Malaysia has 220 beds and provides specialized congenital heart disease services.
Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.
Fortis Hospital offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 2006, the JCI, NABH accredited hospital is located in Mohali, India and has 276 beds, providing comprehensive cardiac care for local and international patients.
Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.
Fortis Hospital, Mulund is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2002, the JCI, NABH- accredited hospital is situated in Mumbai, India and has 315 beds.
Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.
Manipal Hospital, Hebbal offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 1991, the NABL, NABH accredited hospital is located in Bangalore, India and has 280 beds, providing comprehensive cardiac care for local and international patients.
Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.
Max Super Speciality Hospital, Saket is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2006, the JCI, NABH- accredited hospital is situated in Delhi, India and has 539 beds.
Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.
Gurgaon, India
Fortis Memorial Research Institute provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 2013, the JCI, NABH, NABL accredited hospital is located in Gurgaon, India and operates 311 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.
Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.
| Speciality | Cardiac Sciences |
| Procedure | Device Closure of ASD (Amplatzer Septal Occluder) |
| Success Rate | 95-98% |
| Recovery Time | 1 to 2 days |
| Treatment Time | 2 to 3 hours |
| Chances of Recurrence | 1-2% |
An atrial septal defect is an opening in the wall of the heart that can cause mixing of the blood between the heart’s upper chambers, called atria. This is a minimally invasive procedure that involves inserting a special device, called the Amplatzer Septal Occluder, through a catheter into the heart. The device is positioned to cover the ASD, allowing the tissue to grow over it, effectively sealing the hole.
The ASD device closure procedure is primarily used to treat Atrial Septal Defects, which are congenital heart conditions present at birth. It is suitable for certain patients who have smaller atrial septal openings or less serious conditions that can be corrected without open-heart surgery. An experienced cardiac surgeon will diagnose the type of ASD and then suggest the Amplatzer Septal Occluder-based procedure.
After the atrial septal defect closure, patients typically spend a short time in the hospital for observation. The recovery process is relatively quick, with minimal pain and scarring. Most patients can resume their normal activities within a few days to a week, but strenuous activities may be restricted for a few weeks after the surgery. Regular follow-up visits with the cardiologist are recommended to check the progress and ensure the effectiveness of the device after ASD closure is performed.
